Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 6 June 2017, 19:39 HKT/SGT
Share:
Shandong Luoxin Pharmaceutical's H Shares Trading is Suspended from 6 June 2017 until its Delisting on 16 June 2017
- The Liquidity of the H Shares May be Severely Reduced after Delisting on 16 June 2017
- The Latest Time and Date for the Offer Remaining Open for Acceptance is 4:00 p.m. on 26 June 2017

HONG KONG, June 6, 2017 - (ACN Newswire) - Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. ("Shandong Luoxin Pharmaceutical" or the "Company") (stock code: 8058) has announced that the trading in its H Shares has been suspended from today and will remain suspended until the withdrawal of listing of the H Shares from the Stock Exchange from 9:00 a.m. on 16 June 2017.

Giant Star Global (HK) Limited and Ally Bridge Flagship LX (HK) Limited, being the Joint Offerors, have no rights under the laws of the PRC and the articles of association of the Company to compulsorily acquire the H Shares that are not tendered for acceptance pursuant to the Offer. Accordingly, the H Shareholders are reminded that if they do not accept the Offer and the Offer subsequently becomes unconditional in all respects, and the H Shares are delisted from the Stock Exchange, this will result in the H Shareholders holding securities that are not listed on the Stock Exchange and the liquidity of the H Shares may be severely reduced.

Unless the Offer is extended, the latest time and date for acceptance of the Offer will be 4:00 p.m. on 26 June 2017 ("Closing Date") and the latest date for posting of remittances for the amounts due under the Offer in respect of valid acceptances received at or before the latest time for acceptances of the Offer on the Closing Date will be 5 July 2017.



June 6, 2017 19:39 HKT/SGT
Topic: Press release summary
Sectors: Daily Finance, HealthCare
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2017 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Singapore Institutes Collaborate with Samsung Medical Center to Improve Treatment of Liver Cancer  
Dec 14, 2017 10:00 HKT/SGT
DENSO and Toyota Tsusho to Conduct a Test Applying a Quantum Computer to Analyze IoT Data with a Commercial Application  
Dec 14, 2017 08:00 HKT/SGT
Gemalto Rejects Unsolicited and Conditional Proposal by Atos  
Dec 14, 2017 04:00 HKT/SGT
WARC Awards 2018 - Effective Content Strategy jury announced  
Dec 13, 2017 20:00 HKT/SGT
Danfoss Drives Southeast Asia Energy Efficiency Tour to Help Thailand Maintain Progressive Economic Momentum  
Dec 13, 2017 19:30 HKT/SGT
mybitwallet introduces 24/7 currency exchange services  
Dec 13, 2017 18:30 HKT/SGT
Toyota and Panasonic to Start Feasibility Study of Joint Automotive Prismatic Battery Business  
Dec 13, 2017 17:04 HKT/SGT
CASBAA Lauds Indian Ease of Doing Business; Calls for Policy Reforms for Broadcast & Satellite Industries  
Dec 13, 2017 17:00 HKT/SGT
DHL and Air Hong Kong extend their relationship with a new 15-year agreement  
Dec 13, 2017 17:00 HKT/SGT
Eisai's Aricept Approved for Additional Indication of Severe Alzheimer's Disease in China  
Dec 13, 2017 15:59 HKT/SGT
More Press release >>
 News Alerts
Copyright © 2017 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6721 7212

Connect With us: